Continuous aircraft mapping (and monitoring)

Phase 1 mapping establishes baseline aircraft environmental performance. Phase 2 continuous monitoring demonstrates consistent stability across thousands of flights. This statistical evidence proves whether passive containers maintain pharmaceutical-grade conditions on your specific routes and aircraft types – eliminating the "we cannot prove it works" blocker that forces active ULD over-investment.

Typical outcome: validation for passive ULD deployment on 70-85% of flights, with potential annual savings of $15-30M for mid-size fleets through reduced ULD capital costs and fuel savings from weight reduction.

Phase 1 (initial mapping): 4-8 weeks, depending on route coverage and flight frequency. Includes sensor installation, data collection across operational flights, analysis, and mapping report delivery.

Phase 2 (permanent infrastructure): 6-12 week,s including FAA documentation review, sensor installation during scheduled maintenance, system integration, and validation.

Total timeline: 3-5 months from contract to continuous validation state. However, Phase 1 mapping data provides immediate value – you have baseline environmental proof for customer contracts and passive ULD validation before permanent sensors are installed.

Aircraft CMM complements your current approaches. Facility-level environmental control (aircraft CMM + warehouse CMM) supports risk-based deployment of shipment-level monitoring rather than universal deployment – potential cost reduction while maintaining compliance.

For validation processes, aircraft CMM provides environmental data that validation teams need for transport qualification studies. Integration with Eupry's platform means aircraft environmental data, shipment monitoring data, and warehouse data flow into one audit-ready system.

Your CMM validation adapts based on change scope:

• **Minor operational adjustments **(schedule changes, loading sequence modifications): No action required – ongoing monitoring automatically captures impact.
• New routes on validated aircraft types: Brief supplemental mapping study (1-2 flights) to confirm environmental performance, then add to permanent monitoring.
• New aircraft added to fleet: Full Phase 1 + Phase 2 implementation for that specific aircraft.
• Route discontinuation: Sensors can be redeployed to new aircraft during scheduled maintenance.

Eupry provides change control documentation for all scenarios to maintain a continuous validation state.

Eupry provides ROI calculation templates with three quantifiable value streams:

1. Operational cost reduction: 15-minute product release eliminates days of holding costs. For high-value biologics, this represents $50-150k per delayed shipment.
2. ULD fleet optimization: Active to passive transition typically generates significant annual savings for mid-size fleets through reduced ULD capital costs plus fuel savings from weight reduction (up to 19 tonnes per Boeing 767 flight translates to approximately 3,600 liters of fuel saved per transatlantic crossing).
3. Compliance cost reduction: CMM implementation reduces the total cost of ownership by 20-30% over 3-5 years by consolidating vendors for monitoring, mapping, and calibration.

Typical payback period: 8-14 months. Strategic value (pharma-readiness for billion-dollar contracts, CEIV certification acceleration, competitive differentiation) often exceeds direct cost savings.

Eupry functions as your technical compliance partner during audits:

• Pre-audit documentation: Mapping reports, continuous validation summaries, calibration certificates, system validation documentation
• Audit support: Our validation engineers join inspector walkthroughs (on-site or virtual) to explain the CMM framework and answer technical questions
• Post-audit response: We help draft responses to inspector observations related to aircraft temperature control
• Customer-facing materials: White-labeled presentations for your sales teams to demonstrate pharma-readiness to prospective customers

Goal: turn your aircraft CMM implementation into a competitive differentiator that wins contracts.